The Potential of Cancer Biomarkers : From Discovery to Clinical Application. This item is unavailable.
Language: English
Published by Elsevier Science Jun 2025, 2025
- Hardcover
- New
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
AbeBooks seller since August 14, 2006
Condition: New
US$ 259.66
Item description from seller
Neuware - The Potential of Biomarkers: From Discovery to Clinical Application addresses the challenges related to knowledge dissemination, interdisciplinary understanding, diagnostic complexity, quality assurance, patient care, research advancement, education, and professional development within the field of clinical biochemistry. The book provides a holistic solution by offering comprehensive insights and practical guidance to a diverse audience, contributing to the enhancement of healthcare and biomedical research. Each chapter explores the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.…
Seller Inventory # 9780443292798
- Title
- The Potential of Cancer Biomarkers : From Discovery to Clinical Application
- Author
- Pranav Kumar Prabhakar
- Publisher
- Elsevier Science Jun 2025
- Publication year
- 2025
- Condition
- Neu
- Binding
- Buch
- Language
- English
- ISBN 10
- 0443292795
- ISBN 13
- 9780443292798
- Item weight
- 975 grams
- Dimensions
- 239x200x25 mm
Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.
- Presents the impact of biomarkers on early detection, prognosis, and personalized treatment strategies
- Incudes ethical and regulatory considerations surrounding biomarker use, guiding policymakers and ethicists through the complex terrain of biomarker-driven healthcare decisions
- Highlights the clinical relevance of cancer biomarkers by showcasing real-world case studies and examples of how biomarkers have been utilized to improve cancer diagnosis, personalize treatment plans, and monitor treatment responses
"Synopsis" may belong to another edition of this title.
About the Author
Pranav Kumar Prabhakar is Professor and Head of the Department of Biotechnology, School of Engineering and Technology, Nagaland University, Kohima, India. His research focuses on understanding molecular mechanisms involved in metabolic disorders, particularly diabetes, and on developing strategies for oral insulin delivery using natural products and biotechnology-based approaches. He is actively involved in research, academic mentoring, peer review, and editorial activities within the biomedical and biotechnology fields. His professional interests include translational research, signaling pathways associated with metabolic diseases, and the application of biotechnology to improve therapeutic outcomes. He contributes to scientific and academic initiatives that support advancements in biotechnology and healthcare research.
"About the title" may belong to another edition of this title.